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Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Laenggassstrasse 122, 3012, Bern, SwitzerlandBacillus anthracis, a Gram-positive spore forming rod-shaped bacte- In this issue of EBioMedicine, Keim and colleagues (Keim et al.,
rium, is the causative agent of anthrax. This zoonotic disease principally
affects herbivores but B. anthracis can also infect other livestock and
wildlife species (WHO, 1998). Human cases mainly occur sporadically
and infectionsmostly follow direct or indirect contact with contaminat-
ed animal products. Three major forms of human anthrax are described
in the literature: cutaneous, gastrointestinal and pulmonary. All these
forms can successively lead to septicemia and meningitis. The develop-
ment of a speciﬁc clinical manifestation is dependent upon the route of
infection (WHO, 1998). Recently, growing concern was raised by re-
ports describing a new form of anthrax found in heroin users resulting
from the injection of the drug contaminated with spores of
B. anthracis (Hanczaruk et al., 2014). Symptoms of injectional anthrax
(IA) aremore severe than those observed in classical cutaneous anthrax
and clinical outcome is poor (Berger et al., 2014). Two outbreaks of IA
occurred in 2009–2010 (UK, Germany) and in 2012–2013 (Denmark,
France, Germany, UK), respectively (Berger et al., 2014). The subsequent
investigations performed to determine the source of infection involved
multi-disciplinary teams and turned out to be a complicated task as a
consequence of the illegal aspects related to heroin production, distri-
bution and use (Team NAOC, 2011). Among the large amount of data
collected during these investigations, genotyping of strains of
B. anthracis was fundamental (Price et al., 2012).
The recent improvements in the ﬁeld of whole genome sequencing
(WGS) opened up a large panel of applications for bacterial research
and diagnostics. However, WGS generates an enormous quantity of
data and it is essential to maximize exploitation of the produced infor-
mation for epidemiological and evolutionary studies. Public health au-
thorities need typing of pathogenic bacterial isolates to plan and
implement disease surveillance and rapid outbreak response (Sabat
et al., 2013). This facilitates a better understanding of the dynamics of
epidemic events and improves traceability of sources of infection.
From this point of view, WGS allows a higher resolution for typing bac-
teria than the previously available methods based onmolecular biology
techniques (Bertelli and Greub, 2013). Moreover, the comparison of
genomes and consequent assessment of variation among related and
unrelated isolates enables the selection of adequate genetic markers
for rapid screening of isolates.DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.10.004.
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how to take full advantage of genomic data focusing principally on sin-
gle nucleotide polymorphisms. They analyzed the genomes of 60 iso-
lates collected in Europe from IA cases between 2000 and 2013 using
a standardized computational pipeline. Additionally, they screened
two large strain collections consisting of 1293 isolates. These investiga-
tions led to the identiﬁcation of twomajor related clusters of B. anthracis
isolates associated with IA cases: G-I and G-II. All isolates from the
2009–2010 outbreak (Germany, UK) clustered within the G-I group,
while isolates from 2012 to 2013 (Denmark, Germany, UK) and the iso-
late from 2000 (Norway) clustered in the G-II group (Keim et al., 2015).
Consequently, this study suggests the occurrence of at least two
contaminations events from close geographical areas. Previous results
indicated that contamination of heroin likely arose during drug trans-
port/distribution because of the close genetic relationships of IA isolates
to 2 strains isolated in Turkey, which is presumably a transit country for
heroin distribution inWestern Europe (Price et al., 2012). The screening
of the B. anthracis strain collections identiﬁed ﬁve additional strains
related to the IA cases isolated in the US (Keim et al., 2015), probably
originating from imported goods but with unknown origin stressing
the necessity of extensive sampling and detailed documentation of
strains. This is extremely relevant when comparing strains in a global
and historical context. A supplementary ﬁnding of interest in this
study is the observation of genetic variability among isolates within
single patients. The phylogenetic analyses performed by Keim and col-
leagues indicate that the probable cause of this diversity is the infecting
spores (Keim et al., 2015). Co-infectionwithmore than one spore geno-
type was also suggested by Beyer and Turnbull in animals (Beyer and
Turnbull, 2013). However, further in vitro and in vivo experiments in
animalmodels would warrant particular attention to better understand
population dynamics of B. anthracis within hosts and to conﬁrm or re-
fute hypotheses based on observations made in the case of natural
infections.
Beyond the importance of these results for the B. anthracis ﬁeld, this
study highlights four indispensable points to increase efﬁciency and
general knowledge resulting from the WGS: 1) standardization of
computational pipelines, 2) accessibility to large strain collections,
3) availability of complete information about isolates and 4) coupling
data obtained from natural cases to experimental assays. Furthermore,
the massive work performed in B. anthracis genomics made thisthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
1567P. Pilo / EBioMedicine 2 (2015) 1566–1567bacterium an excellent model organism and this approach should be
further applied to other pathogenic bacteria to efﬁciently exploit geno-
mic data for evolutionary studies, public health, forensic microbiology
and biosafety issues.
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